preciosa82

  • https://www.mayoclinic.org/es-es/diseases-conditions/atrial-fibrillation/symptoms-causes/syc-20350624
  • http://cardioalianza.org/las-enfermedades-cardiovasculares/fibrilacion-auricular/
  • https://fundaciondelcorazon.com/informacion-para-pacientes/enfermedades-cardiovasculares/1351-que-es-fibrilacion-auricular.html
  • Andrea Bellone, Massimiliano Etteri, Marco Vettorello,Chiara Bonetti, Dante Clerici, Giancarlo Gini, Carlo Maino, Massimo Mariani, Anna Natalizi, Italo Nessi, Alessandro Rampoldi, Livio Colombo. Cardioversion of acute atrial fibrillation in the emergency department: a prospective randomised trial. Accepted 4 February 2011 Published Online First 21 March 2011
  • Kiera von Besser, MD, PhD, Angela M. Mills, MD, Is Discharge to Home After Emergency Department Cardioversion Safe for the Treatment of Recent-Onset Atrial Fibrillation? Department of Emergency Medicine, Philadelphia, PA. Ann Emerg Med. 2011;58:517-520
  •  

     

    6- Harry JGM Crijns, Lori D Bash, François Chazelle, Jean-Yves Le Heuzey, Thorsten Lewalter, Gregory YH Lip, Aldo P Maggioni, Alfonso Martín, Piotr Ponikowski, Mårten Rosenqvist, Prashanthan Sanders, Mauricio Scanavacca, Alexandra A Bernhardt, Sreevalsa Unniachan, Hemant M Phatak and Anselm K Gitt. RHYTHM-AF: design of an international lregistry on cardioversion of atrial fibrillation and characteristics of participating centers. Netherlands 2012

     

    7- Tapio Hellman| Tuomas Kiviniemi| Ilpo Nuotio| Fausto Biancari| Tuija Vasankari| Juha Hartikainen| Mika Lehto| K.E. Airaksinen| for the FinCV Investigators.  Optimal timing for cardioversion in patients with atrial fibrillation. Finland 2018

    8- Susan S. Kim, MD, Bradley P. Knight, MD, Electrical pharmacology cardioversión for atrial fibrilation. Chicago 2019

    9- Dudink Elton, MD, Essers Brigitte, MSc, Holvoet Wouter, MD, Weijs Bob, MD, PhD, Luermans Justin, MD, PhD, Ramanna Hemanth, MD, PhD, Liem Anho, MD, PhD, van Opstal Jurren, MD, PhD, Dekker Lukas, MD, PhD, van Dijk Vincent, MD, PhD, Lenderink Timo, MD, PhD, Kamp Otto, MD, PhD, Kulker Lennert, MSc, Rienstra Michiel, MD, PhD, Kietselaer Bas, MD, PhD, Alings Marco, MD, PhD, Widdershoven Jos, MD, PhD, Meeder Joan, MD, PhD, Prins Martin, MD, PhD, b van Gelder Isabelle, MD, PhD, l and Crijns Harry, MD, PhD. Acute cardioversión vs a wait-and-see approach forrecent-onset symptomatic atrial fibrillation in the emergency deparment: Rationale and design of the randomized ACWAS trial. Netherlands 2016

    10- Brian G. Cohn, MD,* Samuel M. Keim, MD, MS,† and Donald M. Yealy, MD‡ Is emergency deparment cardioversión of recent-onset atrial fibrillation safe and effective?. EEUU 2013

    11- Blanca CollVinent, Carolina Fuenzalida, Ana Garcia, Alfonso Martin and Oscar Miró. Managent of acute atrial fibrillation in the emergency deparment: a systematic review of recent studies. SPAIN 2012

    12- Rachel Dankner, Amir Shahar, Ilya Novikov Uri Agmon Arnona Ziv Hanoch Hod, Treatment of Stable Atrial Fibrillation in the Emergency Deparment: a population-based comparison of electrical direct-current versus pharmacological cardioversion or conservative management. ISRAEL 2009

    13- Anselm K. Gitt , Wenefrieda Smolka ,Galin Michailov ,Alexandra Bernhardt , David Pittrow ,Thorsten Lewalter Types and outcomes of cardioversión in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study. GERMANY 2013

    14- Curso-taller de identificación y manejo de las arritmias en la urgencia extrahospitalaria. Mayo 2018. SUMMA 112. Madrid. Fernández Domínguez.

    15- Cardioversion eléctrica versus farmacológica para pacientes del servicio de urgencias con fibrilación auricular aguda: un ensayo aleatorio factorial parcial Chen WS, Gao BR, Chen WQ, Li ZZ, Xu ZY, Zhang YH, Yang K, Guan XQ.J Int Med Res. 2013 Aug;41(4):1067-73. doi: 10.1177/0300060513489800. Epub 2013 Jun 21.PMID: 23794519 

    16- Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial  Ian G Stiell, MD , Marco LA Sivilotti, MD, Marco LA Sivilotti,MD,Marco LA Sivilotti, MD,Monica Taljaard,  David Birnie, MD, Alain Vadeboncoeur, MD, Alain Vadeboncoeur, M Alain Vadeboncoeur, MD,Corinne M Hohl, MD.Publicado: 01 de febrero de 2020DOI: https://doi.org/10.1016/S0140-6736(19)32994-0VOLUMEN 395, NÚMERO 10221, P339-349,01 DE FEBRERO DE 2020farmacológica para pacientes del servicioRAFF2): un ensayo aleatorio factorial https://doi.org/10.1016/S0140-6736(19)32994-0